Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446014 · ClinicalTrials.gov registry record
PAD Registry and Fitbit Sub-Study Program
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 41
- Enrollment target
NCT03446014: Completed study, sponsored by University of Pennsylvania.
NCT03446014 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03446014 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The genetic contribution and influence on the progression of peripheral artery disease (PAD) and possible cardiovascular events remains relatively unknown. As a result, the investigators are proposing for the creation of a registry of patients in the University of Pennsylvania Health System who are known to have PAD. The patients in this registry will be systematically monitored by conducting lower extremity ultrasound exams, ankle-brachial index (ABI) measurements, and six minute walk tests which have strong value in the positive diagnoses of PAD. These exams, combined with follow-up quality of life questionnaires, would allow for thorough monitoring of new diagnoses, symptoms, or serious adverse events. Blood will also be drawn looking for genetic biomarkers associated with this disease, which will provide further knowledge on the advancement and potential cardiovascular events associated with this disease. This blood will also be analyzed for components that will provide the investigators with knowledge of the patients overall blood vessel health. Micro RNA will also be evaluated to try to test if proteins and RNA in the blood can be used as predictors for future strokes or heart attacks. These exams will be repeated once annually over a duration of 10 years, with patients having hemodynamic monitoring as well as quality-of-life and cardiovascular events recorded at each visit. The data obtained from this registry will be compared to a created genetic profile looking for any genetic contribution to these new developments. Furthermore, this knowledge should offer impetus for physicians to target patients with these risk factors for the identification of potential adjustments to care.
Primary Outcome
Patients will be recruited from the University of Pennsylvania Health System via surveying of physician's clinics and various databases. Appropriate clinical staff will be informed of this study and its requirements prior to a patient's enrollment. As a result, routine care or other medical procedures of the patient will not be interfered with.
Interventions
- DEVICE Fitbit Sub-Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
What the finished NCT03446014 record still lists
NCT03446014 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fitbit Sub-Study is the first listed.
NCT03446014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03446014 about?
NCT03446014 is a clinical study titled "PAD Registry and Fitbit Sub-Study Program". The genetic contribution and influence on the progression of peripheral artery disease (PAD) and possible cardiovascular events remains relatively unknown. As a result, the investigators are proposing for the creation of a registry of patients in the University of Pennsylvania Health System who are ...
What is the current status of trial NCT03446014?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT03446014?
The interventions under investigation include: Fitbit Sub-Study (DEVICE).
Who is sponsoring clinical trial NCT03446014?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia